The changes in insulin signaling may be induced by pro-inflammatory cytokines and adipokines secreted from both the adipose tissue and placenta of mothers with GDM [23, 36, 37], which have been previously implicated in insulin resistance among non-pregnant populations [38, 39]. The gene discussed is INS; the disease is gestational diabetes.